Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

Source:http://linkedlifedata.com/resource/pubmed/id/12972523

J. Clin. Oncol. 2003 Sep 15 21 18 3479-82

Download in:

View as

Triples

General Info

PMID
12972523